A Trademark

Trademark Overview


On Wednesday, August 6, 2025, a trademark application was filed for A with the United States Patent and Trademark Office. The USPTO has given the A trademark a serial number of 99323813. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, March 24, 2026. This trademark is owned by Abbott Laboratories. The A trademark is filed in the Medical Instrument Products category with the following description:

Medical diagnostic instruments for diabetes diagnosis and monitoring; medical diagnostic instruments for analyzing, measuring and testing blood, bodily fluids and tissue; medical diagnostic instruments for in vitro diagnostic testing and analysis, namely, sample handlers, sample preparation equipment, equipment for testing bodily fluids for medical diagnosis; medical diagnostic instruments for microbial screening and identification, analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and pathogens; medical and surgical apparatus and instruments, namely, stents, catheters, guide wires, bioabsorbable stents, drug-eluting stents, drug-eluting resorbable scaffolding for use with catheters and stents for use in vascular procedures; medical apparatus and equipment, namely, patient monitor that is for use in electronic acquisition, capture and transmission of medical device status and patient medical and physiological data used in connection with implantabl...
a

General Information


Serial Number99323813
Word MarkA
Filing DateWednesday, August 6, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, March 24, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical diagnostic instruments for diabetes diagnosis and monitoring; medical diagnostic instruments for analyzing, measuring and testing blood, bodily fluids and tissue; medical diagnostic instruments for in vitro diagnostic testing and analysis, namely, sample handlers, sample preparation equipment, equipment for testing bodily fluids for medical diagnosis; medical diagnostic instruments for microbial screening and identification, analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and pathogens; medical and surgical apparatus and instruments, namely, stents, catheters, guide wires, bioabsorbable stents, drug-eluting stents, drug-eluting resorbable scaffolding for use with catheters and stents for use in vascular procedures; medical apparatus and equipment, namely, patient monitor that is for use in electronic acquisition, capture and transmission of medical device status and patient medical and physiological data used in connection with implantable cardiac devices, and external or implantable cardiac therapeutic or diagnostic devices; medical diagnostic instruments for testing patients for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic apparatus and incorporated recorded computer software for analyzing medical data and informing treatment decisions in connection with cardiology conditions, chronic pain conditions, movement disorder conditions, and procedures all sold as a unit, for medical diagnostic use; medical apparatus and instruments, namely, blood glucose meters, blood ketone meters, biosensors and biosensor applicators for measuring blood glucose, blood ketone, and blood lactate levels, electrochemical sensors for measuring analyte concentrations in interstitial fluid, electrochemical sensors for monitoring analyte levels in interstitial fluid, electrochemical sensors for monitoring analyte concentrations in bodily fluids, electrochemical sensors for monitoring analyte levels in bodily fluids, electrochemical sensors for monitoring analytes in bodily fluids, needles for injecting insulin, medical infusion pumps for delivering measured amounts of solutions into the bloodstream over time, and insulin pumps; blood, bodily fluid, tissue, and fecal matter medical testing instruments; medical apparatus for monitoring, tracking, and determining analyte concentrations; sensors for monitoring, tracking, and determining analyte concentrations for medical and health purposes; medical apparatus and instruments for monitoring glucose levels; medical apparatus and instruments for monitoring ketones; medical instruments and apparatus for monitoring glucose for health purposes; medical instruments and apparatus for monitoring ketones for health purposes; patient monitoring sensors for monitoring glucose concentrations; patient monitoring sensors for monitoring ketone concentrations; sensor-based glucose monitors for medical purposes; sensor-based ketone monitors for medical purposes; medical devices, namely, catheters and catheter interface modules; medical and surgical catheters; enteral nutritional delivery system, comprised of enteral feeding tubes; breastmilk storage bottle; infant formula storage bottle, sold empty; baby bottles; baby nursers; medical and surgical apparatus and instruments, namely, implantable cardiac devices in the nature of pacemakers, implantable cardioverter defibrillators (ICDs), and pulse generators for cardiac rhythm management; medical stimulation leads for cardiac rhythm management; implantable heart monitors; neurostimulators, namely, implantable systems designed to treat chronic pain and movement disorders; telemetry systems for device communication comprised of remote communication devices used to monitor and manage implanted medical devices across cardiac and neurological therapies; electrophysiology systems comprising primarily of medical sensors for detecting and measuring electrical activity in the body, and electronic nerve stimulators for medical use, and also including amplifiers and recorded operating software therefor, all sold as a unit; catheter-based technologies, namely, balloon dilatation catheters, ablation catheters, mapping catheters, steerable catheters, introducer kits designed for vascular access during diagnostic and interventional cardiovascular procedures, medical guide wires, and stent delivery systems; vascular tools for medical use, namely, drug-eluting and self-expandable stents, occlusion and filtration devices for temporary medical use during interventional procedures to capture debris in blood, thrombectomy systems for treating blood clots, and embolic protection devices for filtering debris during vascular procedures; heart assist devices, namely, ventricular assist devices, catheter pumps, percutaneous heart pumps, blood pumps, and cannula kits comprised of cannulas, inner catheters, and subselectors; prosthetic heart valves, annuloplasty rings and cuffs; surgical instruments and apparatus including coring knives, slitting tools, sewing rings, anastomotic devices, sizers, tunnelers, hand pumping bulbs, and stabilization belts; medical instruments, namely, arterial closure devices; oxygenators for medical use; perfusion tubing for medical use; braided intravascular sheaths for medical use; medical apparatus, namely, bleed back control valves comprised of artificial materials; diagnostic sensors, namely, specialized point-of-care cartridges for clinical diagnostics; delivery catheters; wearable external components for heart assist devices, namely, computer display monitors used in direct association with cardiac rhythm management; medical imaging and navigation systems comprised of medical ultrasound imaging apparatus and medical optical coherence tomography apparatus for 2D and 3D localization of medical images; diagnostic apparatus for the medical analysis of bodily fluids and tissue; cartridges, sold empty, for use in portable clinical blood analyzers for medical use; medical specimen collection kit, consisting of medical diagnostic instruments for the analysis of bodily fluids and tissue; microbial tubes for blood testing; blood testing apparatus; electronic cartridges, sold empty, for use in portable clinical blood analyzers; diagnostic apparatus for medical purposes, namely, for diagnosing pregnancy, fertility, and infectious diseases; medical diagnostic apparatus and instruments for detecting the presence and measuring the level of drugs and alcohol in blood and other body fluids; medical apparatus and instruments for the screening of drugs and alcohol, namely, medical diagnostic devices for analyzing blood and other bodily fluids for the presence of drugs and alcohol; medical instruments, namely, self-processing diagnostic instrument for processing of test cartridges containing chemical reagents for in-vitro diagnostic medical testing; medical devices, namely, camera-based instruments for reading and interpreting lateral flow assays for medical diagnostic and treatment purposes; medical devices, namely, camera-based instruments for reading and interpreting in vitro diagnostic tests for influenza, strep, pneumonia, and legionella; medical diagnostic instruments and parts therefor for molecular diagnostic analysis of infectious disease; medical diagnostic analyzers and replacement parts therefor for detecting and managing infectious diseases; medical apparatus for determining and analyzing in vitro molecular interactions; medical apparatus for analyzing molecules, cells, tissues and organisms for detecting and managing infectious diseases; medical apparatus for analyzing nucleic acid and proteins for diagnosis and testing of infectious diseases; medical instruments used for blood, bodily fluid and tissue testing; nucleic acid medical testing instruments for diagnosis and management of infectious diseases; medical diagnostic instruments for detection of infectious diseases; hematology analyzers for medical diagnostic use; clinical chemistry analyzers for medical diagnostic use in testing bodily fluids; immunoassay analyzers for medical diagnostic use; blood screening instruments for medical use; medical diagnostic instruments for in vitro diagnostic testing and analysis of blood, urine, and other body fluids for infectious diseases, biomarkers, and chemical imbalances; molecular diagnostic instruments for the analysis of body fluids for medical purposes; medical diagnostic instruments, namely, sample handlers, sample preparation equipment, equipment for testing bodily fluids for medical diagnosis; specimen collection kits used in connection with in vitro diagnostics comprised of transport tubes, transport packaging, sterile swabs, transfer pipettes, sample tubes, instructions, sample receivers, test bases, transfer cartridges, quality controls, test cards, extraction reagents, and control swabs; blood analyzing instruments for medical diagnostic purposes; medical diagnostic analyzers for measuring, testing and analyzing body fluids; cartridges, sold empty, chambers and chamber trays for medical use in medical diagnostic blood analyzers, medical diagnostic hematology analyzers, and medical diagnostic analyzers for measuring, testing and analyzing body fluids.
Description of MarkThe mark consists of a stylized letter "a" with an elongated top and curved lines which create a rounded shape.
Pseudo MarkABBOTT

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, August 6, 2025
Primary Code010
First Use Anywhere DateMonday, August 30, 1982
First Use In Commerce DateMonday, August 30, 1982

Trademark Owner History


Party NameAbbott Laboratories
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAbbott Park, IL 60064
US

Trademark Events


Event DateEvent Description
Wednesday, August 6, 2025NEW APPLICATION ENTERED
Wednesday, August 6, 2025APPLICATION FILING RECEIPT MAILED
Monday, January 5, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 6, 2026ASSIGNED TO EXAMINER
Monday, January 12, 2026NON-FINAL ACTION WRITTEN
Monday, January 12, 2026NON-FINAL ACTION E-MAILED
Monday, January 12, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 11, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 11, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 11, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 11, 2026TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 24, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 24, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 24, 2026TEAS/EMAIL CORRESPONDENCE ENTERED